相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Therapeutic potential of opioid/cannabinoid combinations in humans: Review of the evidence
Shanna Babalonis et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)
Endocannabinoid Modulation of Microglial Phenotypes in Neuropathology
Mikiei Tanaka et al.
FRONTIERS IN NEUROLOGY (2020)
Toll-Like Receptor 4 (TLR4)/Opioid Receptor Pathway Crosstalk and Impact on Opioid Analgesia, Immune Function, and Gastrointestinal Motility
Peng Zhang et al.
FRONTIERS IN IMMUNOLOGY (2020)
Selective breeding for high alcohol preference is associated with increased sensitivity to cannabinoid reward within the nucleus accumbens shell
Sheketha R. Hauser et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2020)
Opposing roles of CB1 and CB2 cannabinoid receptors in the stimulant and rewarding effects of cocaine
Pedro H. Gobira et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial
Yasmin L. Hurd et al.
AMERICAN JOURNAL OF PSYCHIATRY (2019)
Cannabinoid CB1 and CB2 receptor mechanisms underlie cannabis reward and aversion in rats
Krista J. Spiller et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Δ9-tetrahydrocannabinol attenuates oxycodone self-administration under extended access conditions
Jacques D. Nguyen et al.
NEUROPHARMACOLOGY (2019)
Endocannabinoid Regulation of Reward and Reinforcement through Interaction with Dopamine and Endogenous Opioid Signaling
J. M. Wenzel et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Preclinical Studies of Cannabinoid Reward, Treatments for Cannabis Use Disorder, and Addiction-Related Effects of Cannabinoid Exposure
Leigh V. Panlilio et al.
NEUROPSYCHOPHARMACOLOGY (2018)
It is premature to expand access to medicinal cannabis in hopes of solving the US opioid crisis
Wayne Hall et al.
ADDICTION (2018)
Emerging Evidence for Cannabis' Role in Opioid Use Disorder
Beth Wiese et al.
CANNABIS AND CANNABINOID RESEARCH (2018)
Endocannabinoid-Enhanced Liking in Nucleus Accumbens Shell Hedonic Hotspot Requires Endogenous Opioid Signals
Marci R. Mitchell et al.
CANNABIS AND CANNABINOID RESEARCH (2018)
Bi-directional cannabinoid signalling in the basolateral amygdala controls rewarding and aversive emotional processing via functional regulation of the nucleus accumbens
Tasha Ahmad et al.
ADDICTION BIOLOGY (2017)
Expression of functional cannabinoid CB2 receptor in VTA dopamine neurons in rats
Hai-Ying Zhang et al.
ADDICTION BIOLOGY (2017)
Synergistic attenuation of chronic pain using mu opioid and cannabinoid receptor 2 agonists
Shaness A. Grenald et al.
NEUROPHARMACOLOGY (2017)
Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis
Suzanne Nielsen et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference
Qing-Rong Liu et al.
SCIENTIFIC REPORTS (2017)
CB1 Receptor Antagonism in the Bed Nucleus of the Stria Terminalis Interferes With Affective Opioid Withdrawal in Rats
Kiri L. Wills et al.
BEHAVIORAL NEUROSCIENCE (2017)
Cannabis as a Substitute for Opioid-Based Pain Medication: Patient Self-Report
Amanda Reiman et al.
CANNABIS AND CANNABINOID RESEARCH (2017)
Medical marijuana policies and hospitalizations related to marijuana and opioid pain reliever
Yuyan Shi
DRUG AND ALCOHOL DEPENDENCE (2017)
Medical cannabis access, use, and substitution for prescription opioids and other substances: A survey of authorized medical cannabis patients
Philippe Lucas et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2017)
Double Dissociation of Monoacylglycerol Lipase Inhibition and CB1 Antagonism in the Central Amygdala, Basolateral Amygdala, and the Interoceptive Insular Cortex on the Affective Properties of Acute Naloxone-Precipitated Morphine Withdrawal in Rats
Kiri L. Wills et al.
NEUROPSYCHOPHARMACOLOGY (2016)
State Medical Marijuana Laws and the Prevalence of Opioids Detected Among Fatally Injured Drivers
June H. Kim et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2016)
Opioid withdrawal suppression efficacy of oral dronabinol in opioid dependent humans
Michelle R. Lofwall et al.
DRUG AND ALCOHOL DEPENDENCE (2016)
Antipsychotic-like Effects of M4 Positive Allosteric Modulators Are Mediated by CB2 Receptor-Dependent Inhibition of Dopamine Release
Daniel J. Foster et al.
NEURON (2016)
Blockade of Cannabinoid CB1 receptor attenuates the acquisition of morphine-induced conditioned place preference along with a downregulation of ERK, CREB phosphorylation, and BDNF expression in the nucleus accumbens and hippocampus
Jianbo Zhang et al.
NEUROSCIENCE LETTERS (2016)
Effects of acute and repeated dosing of the synthetic cannabinoid CP55,940 on intracranial self-stimulation in mice
Travis W. Grim et al.
DRUG AND ALCOHOL DEPENDENCE (2015)
The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone
Adam Bisaga et al.
DRUG AND ALCOHOL DEPENDENCE (2015)
The endocannabinoid system in guarding against fear, anxiety and stress
Beat Lutz et al.
NATURE REVIEWS NEUROSCIENCE (2015)
Understanding opioid reward
Howard L. Fields et al.
TRENDS IN NEUROSCIENCES (2015)
Morphine disinhibits glutamatergic input to VTA dopamine neurons and promotes dopamine neuron excitation
Ming Chen et al.
ELIFE (2015)
Species Differences in Cannabinoid Receptor 2 and Receptor Responses to Cocaine Self-Administration in Mice and Rats
Hai-Ying Zhang et al.
NEUROPSYCHOPHARMACOLOGY (2015)
No Evidence for Reduction of Opioid-Withdrawal Symptoms by Cannabis Smoking During a Methadone Dose Taper
David H. Epstein et al.
AMERICAN JOURNAL ON ADDICTIONS (2015)
Regulation of Brain Reward by the Endocannabinoid System: A Critical Review of Behavioral Studies in Animals
S. Vlachou et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Separate GABA Afferents to Dopamine Neurons Mediate Acute Action of Opioids, Development of Tolerance, and Expression of Withdrawal
Aya Matsui et al.
NEURON (2014)
The cannabinoid receptor 2 agonist, β-caryophyllene, reduced voluntary alcohol intake and attenuated ethanol-induced place preference and sensitivity in mice
Shamma Al Mansouri et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2014)
Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice
Hai-Ying Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Role of intra-accumbal cannabinoid CB-1 receptors in the potentiation, acquisition and expression of morphine-induced conditioned place preference
Sara Karimi et al.
BEHAVIOURAL BRAIN RESEARCH (2013)
Involvement of CB1 receptors in the ventral tegmental area in the potentiation of morphine rewarding properties in acquisition but not expression in the conditioned place preference model
Ali Rashidy-Pour et al.
BEHAVIOURAL BRAIN RESEARCH (2013)
Kappa Opioid Receptors on Dopaminergic Neurons Are Necessary for Kappa-Mediated Place Aversion
Vladimir I. Chefer et al.
NEUROPSYCHOPHARMACOLOGY (2013)
CANNABINOID AND OPIOID INTERACTIONS: IMPLICATIONS FOR OPIATE DEPENDENCE AND WITHDRAWAL
J. L. Scavone et al.
NEUROSCIENCE (2013)
Delta opioid receptors in brain function and diseases
Paul Chu Sin Chung et al.
PHARMACOLOGY & THERAPEUTICS (2013)
The periaqueductal gray contributes to bidirectional enhancement of antinociception between morphine and cannabinoids
Adrianne R. Wilson-Poe et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2013)
Opioid receptors: distinct roles in mood disorders
Pierre-Eric Lutz et al.
TRENDS IN NEUROSCIENCES (2013)
Proenkephalin Mediates the Enduring Effects of Adolescent Cannabis Exposure Associated with Adult Opiate Vulnerability
Hilarie C. Tomasiewicz et al.
BIOLOGICAL PSYCHIATRY (2012)
Endocannabinoids Shape Accumbal Encoding of Cue-Motivated Behavior via CB1 Receptor Activation in the Ventral Tegmentum
Erik B. Oleson et al.
NEURON (2012)
Endocannabinoid Signaling and Synaptic Function
Pablo E. Castillo et al.
NEURON (2012)
Decreased Cocaine Motor Sensitization and Self-Administration in Mice Overexpressing Cannabinoid CB2 Receptors
Auxiliadora Aracil-Fernandez et al.
NEUROPSYCHOPHARMACOLOGY (2012)
DISTRIBUTION OF CB1 CANNABINOID RECEPTORS AND THEIR RELATIONSHIP WITH MU-OPIOID RECEPTORS IN THE RAT PERIAQUEDUCTAL GRAY
A. R. Wilson-Poe et al.
NEUROSCIENCE (2012)
Deletion of the δ Opioid Receptor Gene Impairs Place Conditioning But Preserves Morphine Reinforcement
Julie Le Merrer et al.
BIOLOGICAL PSYCHIATRY (2011)
Cannabinoid-Opioid Interaction in Chronic Pain
D. I. Abrams et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Expression of the mRNA coding the cannabinoid receptor 2 in the pallidal complex of Macaca fascicularis
Jose L. Lanciego et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice
Maria S. Garcia-Gutierrez et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Brain cannabinoid CB2 receptors modulate cocaine's actions in mice
Zheng-Xiong Xi et al.
NATURE NEUROSCIENCE (2011)
Neuronal circuits underlying acute morphine action on dopamine neurons
Marion Jalabert et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The delta opioid receptor: an evolving target for the treatment of brain disorders
Amynah A. Pradhan et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
Prevalence of Prescription Opioid-Use Disorder Among Chronic Pain Patients: Comparison of the DSM-5 vs. DSM-4 Diagnostic Criteria
Joseph A. Boscarino et al.
JOURNAL OF ADDICTIVE DISEASES (2011)
Characterization of cannabinoid-1 receptors in the locus coeruleus: Relationship with mu-opioid receptors
Jillian L. Scavone et al.
BRAIN RESEARCH (2010)
Cellular Mechanisms Underlying the Interaction between Cannabinoid and Opioid System
D. Parolaro et al.
CURRENT DRUG TARGETS (2010)
The endocannabinoid system and nondrug rewarding behaviours
Liana Fattore et al.
EXPERIMENTAL NEUROLOGY (2010)
The Endocannabinoid System and Pain
Josee Guindon et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2009)
Augmentation of Morphine-Induced Sensitization but Reduction in Morphine Tolerance and Reward in Delta-Opioid Receptor Knockout Mice
V. I. Chefer et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Adolescent Exposure to Chronic Delta-9-Tetrahydrocannabinol Blocks Opiate Dependence in Maternally Deprived Rats
Lydie J. Morel et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Disruption of NMDAR-dependent burst firing by dopamine neurons provides selective assessment of phasic dopamine-dependent behavior
Larry S. Zweifel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Cannabinoid CB1 receptors of the rat central amygdala mediate anxiety-like behavior: interaction with the opioid system
Mohammad-Reza Zarrindast et al.
BEHAVIOURAL PHARMACOLOGY (2008)
Enzymatic pathways that regulate endocannabinoid signaling in the nervous system
Kay Ahn et al.
CHEMICAL REVIEWS (2008)
μ-Opioid Receptor Forms a Functional Heterodimer With Cannabinoid CB1 Receptor: Electrophysiological and FRET Assay Analysis
Minoru Hojo et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2008)
Noladin ether, a putative endocannabinoid, inhibits mu-opioid receptor activation via CB2 cannabinoid receptors
Estera Paldyova et al.
NEUROCHEMISTRY INTERNATIONAL (2008)
Sex-dependent effects of periadolescent exposure to the cannabinoid agonist CP-55,940 on morphine self-administration behaviour and the endogenous opioid system
Miguel Biscaia et al.
NEUROPHARMACOLOGY (2008)
Multiple pathways involved in the biosynthesis of anandamide
Jie Liu et al.
NEUROPHARMACOLOGY (2008)
Brain Neuronal CB2 Cannabinoid Receptors in Drug Abuse and Depression: From Mice to Human Subjects
Emmanuel S. Onaivi et al.
PLOS ONE (2008)
Adolescent cannabis exposure alters opiate intake and opioid limbic neuronal populations in adult rats
Maria Ellgren et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Prenatal cannabis exposure increases heroin seeking with allostatic changes in limbic enkephalin systems in adulthood
M. Sabrina Spano et al.
BIOLOGICAL PSYCHIATRY (2007)
μ opioid and CB1 cannabinoid receptor interactions:: reciprocal inhibition of receptor signaling and neuritogenesis
Carl Rios et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Endogenous opiates and behavior: 2005
Richard J. Bodnar et al.
PEPTIDES (2006)
Interactions between CB1 cannabinoid and μ opioid receptors mediating inhibition of neurotransmitter release in rat nucleus accumbens core
A. N. M. Schoffelmeer et al.
NEUROPHARMACOLOGY (2006)
Involvement of κ/dynorphin system in WIN 55,212-2 self-administration in mice
Victoria Mendizabal et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Comparison of opioid receptor distributions in the rat central nervous system
Andrew C. Gray et al.
LIFE SCIENCES (2006)
Involvement of the endocannabinoid system in drug addiction
R Maldonado et al.
TRENDS IN NEUROSCIENCES (2006)
Cannabinoid modulation of opiate reinforcement through the ventral striatopallidal pathway
S Caillé et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Targeting dopamine D2 and Cannabinoid-1 (CB1) receptors in rat nucleus accumbens
VM Pickel et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2006)
Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain
JP Gong et al.
BRAIN RESEARCH (2006)
Synergistic affective analgesic interaction between delta-9-tetrahydrocannabinol and morphine
JD Roberts et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Identification and functional characterization of brainstem cannabinoid CB2 receptors
MD Van Sickle et al.
SCIENCE (2005)
Molecular and cellular basis of cannabinoid and opioid interactions
D Viganò et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2005)
Endocannabinoid release from midbrain dopamine neurons: A potential substrate for cannabinoid receptor antagonist treatment of addiction
CR Lupica et al.
NEUROPHARMACOLOGY (2005)
Cannabinoid CB1 antagonist SR 141716A attenuates reinstatement of heroin self-administration in heroin-abstinent rats
L Fattore et al.
NEUROPHARMACOLOGY (2005)
Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons
G Wotherspoon et al.
NEUROSCIENCE (2005)
The opioid antagonist naltrexone reduces the reinforcing effects of Δ9-tetrahydrocannabinol (THC) in squirrel monkeys
Z Justinova et al.
PSYCHOPHARMACOLOGY (2004)
Marijuana and cannabinoid regulation of brain reward circuits
CR Lupica et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
The endocannabinoid system and its therapeutic exploitation
V Di Marzo et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Independent presynaptic and postsynaptic mechanisms regulate endocannabinoid signaling at multiple synapses in the ventral tegmental area
AC Riegel et al.
JOURNAL OF NEUROSCIENCE (2004)
Δ9-Tetrahydrocannabinol-induced conditioned place preference and intracerebroventricular self-administration in rats
D Braida et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Exposure to Δ-9-tetrahydrocannabinol (THC) increases subsequent heroin taking but not heroin's reinforcing efficacy:: A self-administration study in rats
M Solinas et al.
NEUROPSYCHOPHARMACOLOGY (2004)
A cannabinoid receptor antagonist attenuates conditioned place preference but not behavioural sensitization to morphine
ME Singh et al.
BRAIN RESEARCH (2004)
Cannabinoid agonist-induced sensitisation to morphine place preference in mice
C Manzanedo et al.
NEUROREPORT (2004)
Compartment-specific localization of cannabinoid 1 (CB1) and mu-opioid receptors in rat nucleus accumbens
VM Pickel et al.
NEUROSCIENCE (2004)
Mu opioid receptor: a gateway to drug addiction
C Contet et al.
CURRENT OPINION IN NEUROBIOLOGY (2004)
CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid-seeking behaviour in the rat
MS Spano et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Behavioral and molecular changes elicited by acute administration of SR141716 to Δ9-tetrahydrocannabinol-tolerant rats:: an experimental model of cannabinoid abstinence
S González et al.
DRUG AND ALCOHOL DEPENDENCE (2004)
The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio schedules of drug self-administration in rats
M Solinas et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain
D Viganò et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Brain monoglyceride lipase participating in endocannabinoid inactivation
TP Dinh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The endogenous cannabinoid system controls extinction of aversive memories
G Marsicano et al.
NATURE (2002)
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
AC Howlett et al.
PHARMACOLOGICAL REVIEWS (2002)
CB1-cannabinoid and μ-opioid receptor co-localization on postsynaptic target in the rat dorsal horn
C Salio et al.
NEUROREPORT (2001)
Δ9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins:: reduction in morphine withdrawal syndrome without change in rewarding effect
O Valverde et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2001)
Reduction of opioid dependence by the CB1 antagonist SR141716A in mice:: evaluation of the interest in pharmacotherapy of opioid addiction
M Mas-Nieto et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Opioid and cannabinoid receptors share a common pool of GTP-binding proteins in cotransfected cells, but not in cells which endogenously coexpress the receptors
M Shapira et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2000)
Cannabinoid CB1 receptor expression in rat spinal cord
WP Farquhar-Smith et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2000)
Mice deficient for δ- and γ-opioid receptors exhibit opposing alterations of emotional responses
D Filliol et al.
NATURE GENETICS (2000)
Long-term treatment with SR141716A, the CB1 receptor antagonist, influences morphine withdrawal syndrome
T Rubino et al.
LIFE SCIENCES (2000)
A behavioural model to reveal place preference to Delta 9-tetrahydrocannabinol in mice
E Valjent et al.
PSYCHOPHARMACOLOGY (2000)
分享论文
